Abstract Infosys expands into advanced SEO and digital marketing, delivering data-driven strategies to boost visibility and measurable online growth. KATHMANDU ...

Abstract: In recent years, security testing and vulnerability detection in source code have experienced a significant transformation with the adoption of data-driven techniques. This shift has reduced ...

Abstract submission is now open for the ASTM International Conference on Advanced Manufacturing (ICAM 2026), scheduled to take place from September 28 to October 2, 2026, in Orlando, Florida, USA.

Currently my repo(Android & iOS combined) is using java-client version: 8.3.0 I did not update my version since I got issues with the new byte buddy library. I tried ...

OCALA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today detailed a recent abstract containing data from the completed Phase 2 advanced ...

NEW YORK, Sept. 23, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today ...

Abstract Security, the leader in streaming-first security data operations, is unveiling the PAINT (Partnerships, Alliances, and INTegrations) Partner Program, a new initiative that supercharges ...

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK-pathway-driven cancers, today announced positive, ...

Jakarta EE, a working group hosted by the Eclipse Foundation, today announced the general availability of the Jakarta EE 11 Platform, the latest version of its enterprise Java platform. The new ...

The benefit of the addition of perioperative pembrolizumab to standard care with surgery and adjuvant therapy for patients with locally advanced head and neck squamous-cell carcinoma (HNSCC) is ...

REMATCH2201: A phase II study on reducing surgical margins in HPV-negative advanced HNSCC with neoadjuvant PD-1 inhibitor and AP chemotherapy. This is an ASCO Meeting Abstract from the 2025 ASCO ...